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Available online 21 May 2016Lung cancer is largely an environmentally caused disease with poor prognosis. An in vitro transformation model
of human bronchial epithelial cells (HBEC) was used to study long-term effects of tobacco smoke carcinogens on
epithelial-mesenchymal transition (EMT) and the forkhead box transcription factors FOXA1 and FOXA2. CDK4
and hTERT immortalizedHBEC2andHBEC12 cell lineswere exposedweekly to either cigarette smoke condensate
(CSC), benzo[a]pyrene, or methylnitrosourea. Transformed cell lines were established from soft-agar colonies
after 12 weeks of exposure. HBEC12 was transformed by all exposures while HBEC2 was only transformed by
CSC. Untransformed HBEC2 showed little invasive capacity, whereas transformed cell lines completely closed
the gap in a matrigel scratch wound assay. CDH1was down-regulated in all of the transformed cell lines. In con-
trast, CDH2 was up-regulated in both HBEC2 and one of the HBEC12 transformed cell lines. Furthermore, trans-
formed cells showed activation of EMTmarkers including SNAI1, ZEB1, VIM, andMMP2. All transformed cell lines
had signiﬁcant down-regulation of FOXA1 and FOXA2, indicating a possible role in cell transformation and EMT.
ChIP analysis showed increased binding of Histone-H3 and macroH2A in FOXA1 and FOXA2 in the transformed
HBEC2 cell lines, indicating a compact chromatin. In conclusion, long-term carcinogen exposure lead to down-
regulation of FOXA1 and FOXA2 concomitantly with the occurrence of EMT and in vitro transformation in HBEC
cells.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Lung cancer is the most common cause of cancer death worldwide
(Ferlay et al., 2015). The advances in the treatment of lung cancer
have been slow with current 5-year relative survival rates below 20%
(Siegel et al., 2015). The single most important etiological factor for
lung cancer is tobacco smoke but also occupational and environmental
carcinogens contribute signiﬁcantly to the disease, making it largely
an environmentally induced cancer (Dela Cruz et al., 2011). In Norway,tin immunoprecipitation; CSC,
mal transition; HBEC, human
a; NSCLC, non-small cell lung
qPCR, quantitative PCR; TF,
s from the Norwegian Cancer
iologicalWorking Environment,
onment, National Institute of
033 Oslo, Norway.
).
. This is an open access article underit is estimated that approximately 20% of all lung cancer cases may be a
result of occupational exposure (Haldorsen et al., 2004).
The development of human lung carcinoma is a long-term process
typically spanning several decades, resulting from chronic exposure to
environmental carcinogens. Cigarette smoke is composed of a complex
chemical mixture containing around 5700 different compounds of
which 76 are classiﬁed as carcinogenic in laboratory animals or humans
(Hecht, 2012; Rodgman and Perfetti, 2013). Based on their potency and
levels, polycyclic aromatic hydrocarbons (PAH), N-nitrosamines,
aromatic amines, aldehydes, ethylene epoxides, 1,3-butadiene, and
benzene are considered the most important carcinogens in cigarette
smoke (Hecht, 2006).
Epithelial-to-mesenchymal transition (EMT) is a complex
reprogramming process providing epithelial cells with a mesenchymal
phenotype. EMT takes place via several different pathways and plays
an essential role during organogenesis, tissue repair and ﬁbrosis, in ad-
dition to tumor invasion and metastasis (Thiery et al., 2009). In cancer
development, transcriptional changes occurring during EMT may in-
volve the loss of epithelial markers (E-cadherin, α- and ϒ-catenin)
and the gain of mesenchymal cell markers (N-cadherin, vimentin, andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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down-regulation of E-cadherin (CDH1) and up-regulation of N-cadherin
(CDH2), is a typical EMT marker in cancer. The resulting mesenchymal
cells display a more stem cell like phenotype with increased migratory
capacity and increased invasiveness (Morel et al., 2012).
Several studies have reported reduced levels of E-cadherin in lung
tumors (Bremnes et al., 2002; Nagathihalli et al., 2012). This may be
caused by direct or indirect repression of transcription by several tran-
scription factors (TFs). Two zinc ﬁnger TF families, Snail (SNAI1 and
SNAI2) and ZEB (ZEB1 and ZEB2), repress CDH1 gene expression by di-
rectly binding to E-box elements in theCDH1promoter. Other transcrip-
tion factors, such as the basic helix-loop-helix TF TWIST, down-regulate
E-cadherin levels by binding E-boxes in CDH1 or in other repressors of
CDH1 (Pozharskaya et al., 2009; Vesuna et al., 2008). Epigenetic regula-
tion of the CDH1 gene may also be important and CDH1 promoter
hypermethylation represents a prognostic factor for non-small cell
lung cancer (NSCLC) (Yoshiura et al., 1995). TWIST actively induces
transcription of CDH2 (Alexander et al., 2006), making it a critical player
in establishing the cadherin switch. The expression of certain matrix
metalloproteinases (including MMP2 and MMP9) are increased during
EMT and cell invasion. These proteins proteolytically degrade compo-
nents in the extracellular matrix, rendering the cell able to migrate
and invade (Ura et al., 1989).
FOXA1 and FOXA2 are pioneer TFs that bind to and open condensed
chromatin, making response elements in regulatory regions available
for binding of other TFs. FOXA1 and FOXA2 are considered to play an es-
sential role in maintaining the epithelial phenotype, and loss of FOXA1
and FOXA2 expression has been reported as essential for EMT in some
tissues, including lung (Song et al., 2010; Tang et al., 2011; Wang
et al., 2013). Moreover, FOXA1 expression has been associated with
metastasis and low survival in lung squamous cell carcinoma (Deutsch
et al., 2012). The chromatin “opening” action of FOXA proteins provides
the foundation for hormone receptor interactions with DNA, and their
deregulation may result in reprogramming of gene regulatory actions
(Carroll et al., 2005). Interestingly, whereas FOXA1may be up-regulated
by gene ampliﬁcation, FOXA2 has been found to be down-regulated in
association with promoter hypermethylation in lung cancers (Basseres
et al., 2012; Lin et al., 2002). The role of FOXA1/2 in cancer is not
completely understood and may be tissue dependent. For instance,
opposing roles of FOXA1 are observed during cancer development in
the prostate and breast (Robinson and Carroll, 2012).
A large number of studies have characterized mechanisms in-
volved in lung carcinogenesis in vitro (Gazdar et al., 2010). In the
past, many of these have relied on already tumorigenic lung cell
lines or bronchial epithelial cell lines immortalized with viral onco-
genes (e.g. A549, BEAS-2B, and others). Such cell lines often show
mutated TP53 and/or impaired TP53 signaling, which makes them
less suited for studies of early steps during lung carcinogenesis. In
the present study we used two human bronchial epithelial cell
lines immortalized in the absence of viral oncoproteins (HBEC2-KT
and HBEC12-KT). The HBECs cluster with primary lung epithelial
cells in global gene expression analysis, show UV-inducible, wild
type TP53, a high degree of chromosomal stability, have retained
the ability to differentiate and may represent a relevant model for
in vitro lung epithelial carcinogenesis studies (Delgado et al., 2011;
Ramirez et al., 2004).
Little is known about the role of FOXA1 and FOXA2 during chemical
carcinogenesis in human lung cells. Here, in vitro transformation of
human bronchial epithelial cell lines (HBECs) was studied after long-
term exposure to a cigarette smoke condensate (CSC), the model PAH
benzo[a]pyrene (B[a]P), and methylnitrosourea (MNU). Transformed
cell lines show characteristics of loss of epithelial and gain ofmesenchy-
mal morphology and phenotype. Concomitant down-regulation of the
FOXA1 and FOXA2 factors in both pre-transformed and transformed
cells was demonstrated by gene expression analysis and confocal im-
munoﬂuorescence microscopy. Reduced expression of FOXA genesmay be due to epigenetic regulation indicated by altered histone
marks in regulatory regions of the genes.
2. Materials and methods
2.1. Cell culture
The hTERT and Cdk4 immortalized human bronchial epithelial cell
lines HBEC2-KT (male donor, 68 y.o., NSCLC, smoker) and HBEC12-KT
(female donor, 55 y.o., NSCLC, ex-smoker) were a kind gift from Dr.
John D. Minna (Ramirez et al., 2004). The HBEC lines have recently
been authenticated by the Leibniz-Institut DSMZ (Deutsche Sammlung
von Mikroorganismen und Zellkulturen GmbH). Cells were grown in
LHC-9 media (Thermo Fisher Sci.) supplemented with FBS (10%). For
transformation cells were seeded in 6-well multidishes with a seeding
density of 1 × 104 cells per well (HBEC2) and 2 × 104 cells per well
(HBEC12). Seeding density was determined in order to get conﬂuent
wells after 1 week of incubation. The cells were incubated in a humidi-
ﬁed atmosphere at 37 °C, 5% CO2.
2.2. Cell transformation
Cytotoxicity was assessed using CellTiter-Blue cell viability assay
(Promega). Cells were passaged (day 1) and seeded in quadruplicates
in 6-well multidishes. During the whole experiment, cells from each of
these wells were kept separate. Twenty-four hours after passaging,
the cells were exposed to B[a]P (high dose: 1.0 μM, low dose: 0.3 μM)
or CSC (high dose: 3.0 μg/μl, low dose: 1.0 μg/μl). Due to different toxic-
ity of MNU between the cell lines 2KT and 12KT, the doses used were
1.0 μM and 0.5 μM, respectively. Vehicle control was DMSO (0.1%).
After 72 h of exposure the culture media were removed, the cells
were washed with PBS, and fresh media were added. The cells were
then incubated for 72 h before beingpassaged again. This seven days ex-
posure routinewas repeated for a total duration of 12 weeks (outline of
experimental design in Supplementary Fig. S1). After the 6th, 9th, and
12th exposure, a fraction of cells from each treatment was assayed for
growth in soft-agar. In addition, cells were seeded for gene expression
analysis of pre-transformed cells.
2.3. Selection in soft-agar
The soft-agar assaywas performed in a 6-wellmultidish. The bottom
and top layer had an agarose concentration of 0.7% (1.5ml perwell) and
0.35% (1.0 ml per well), respectively. Seeding density was 1 × 104 cells
per well. Quadruplicates were seeded for each of the four replicates for
each treatment (total of 16 wells soft-agar for each treatment). Soft-
agar cultures were incubated for 3–4 weeks before colonies were de-
tected. Colonieswere then isolated using amicropipette and transferred
to a 24-well multidish. Cells were incubated until conﬂuency and then
passaged to 100 mm petri dishes. Soft agar assay was carried out
twice to ensure stable transformation and true clonality of the isolated
cell lines. The cell lines established from soft agar colonieswere cryopre-
served. Transformed cell lines established from soft-agar colonies after
12 weeks of carcinogen exposure were used for further studies.
2.4. Cell migration and invasion assay
Migration and invasion studies were performed using IncuCyte
Zoom Live Cell Imaging microscope and software (Essen BioScience).
Cells were seeded on matrigel (BD Biosciences, 356230) coated
ImageLock 96-well plates (2.5 × 104 cells/well). After 24 h, a scratch
wound was made in the conﬂuent cell layer using the WoundMaker
toll (Essen BioScience). For migration, the plates were readily placed
within an IncuCyte Zoom microscope inside the incubator and images
were acquired every hour for up to 72 h to monitor closure of the
wound. For assessment of invasion, the scratch wounded cell layer
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and images were acquired in the same manner.
2.5. Gene expression analysis
Total RNAwas isolated from cultured cells by the Izol-RNA Lysis Re-
agent (5 PRIME). Reverse transcription was done using qScript cDNA
synthesis kit (Quanta Biosciences). Analysis of relative gene expression
was performed by quantitative PCR (qPCR) using the ABI Prism 7900HT
(Life Technologies) and PerfeCTa SYBR green fast mix (Quanta Biosci-
ences). All gene expression levels are normalized to β-actin levels and
are calculated by the ΔΔCq method (Livak and Schmittgen, 2001).
2.6. Immunoﬂuorescence confocal microscopy
HBEC2 and HBEC12 control and transformed cells were grown on
cover slips until conﬂuent. Cells were ﬁxed for 20min in 4% paraformal-
dehyde and permeabilized with 0.1% Triton X-100 in PBS for 5 min.
Cover slips were blocked by incubation with 5% BSA in 0.1% PBS-Triton
X-100 for 1 h at room temperature and incubated overnight with
primary antibodies against E-Cadherin (ab40772, Abcam), N-Cadherin
(ab98952), FOXA1 (ab23738), or FOXA2 (sc6554, Santa Cruz Biotech-
nology) in 3% BSA in PBS, at 4 °C in a humidiﬁed chamber. Secondary
antibody Alexa ﬂuor 488-linked goat anti-rabbit IgG (A11070, Life
Technologies), Alexa ﬂuor 647-linked goat anti-mouse IgG (A323) or
Alexa ﬂuor 488-linked donkey anti-goat IgG (A11055), (all fromMolec-
ular Probes, Life Technologies) were left on the cells for 1 h at room
temperature in a humidiﬁed chamber. To visualize cell nuclei cells
were counterstained with Hoechst (Sigma-Aldrich). Fluorescence
signals were monitored using a pinhole confocal microscope (Zeiss
Oberkochen, Germany) and images were acquired with an AxioCam
camera (Zeiss).
2.7. Chromatin immunoprecipitation (ChIP)
Chromatin cross-linking and nuclei isolation was performed
using truChIP chromatin shearing kit (Covaris) according to the
manufacturer's protocol. Brieﬂy, chromatin was cross-linked for two
minutes by adding formaldehyde (1%) to the cell culture media. The
cross-linking was subsequently quenched for 5 min. The cell pellet
was collected by scraping, then washed and lysed. Chromatin was
sheared using Covaris ultrasonicatorM220. The IPwas performed as de-
scribed by Cortazár et al., with some modiﬁcations (Cortazar et al.,
2011). Brieﬂy, 25 μg chromatin was used in each ChIP with 2 μg of the
appropriate antibody against H3 (Abcam, Ab1791), H2A.Z (Abcam,
Ab4174), macroH2A (Abcam, Ab37264), or negative control rabbit im-
munoglobulins (DacoCytomation, X-0903). For each cell line, chromatin
from four independent experimentswas pooled. Negative control ChIPs
were conducted in parallel with every experiment. ChIP DNA-eluates
were assayed by qPCR with primers targeting 6 regions in FOXA1 and
4 regions in FOXA2 (Supplementary Table 1). For all qPCR assays eluates
from the negative control (mock IgG) were included. Cq values for eachTable 1
Transformation of HBEC cells after 12 weeks of exposure to tobacco smoke carcinogens.
DMSO B[a]P
(0.3 μM)
B[a
(1.0
HBEC2 Neg. Neg. Neg
Names of transformed cell lines
HBEC12 Neg. + +
Names of transformed cell lines T12KT-B[a]P-L T12
(A–D) (A–
“+” indicates transformation, while neg. indicates that no colonies were detected after the parsample was normalized to the Cq of an non-immunoprecipitated
(IP input) sample and all results are presented as per cent of input.
2.8. Statistical analysis
Calculation of mean and standard deviation of qPCR results was
done using the Pandas package in Python. Gene expression plots were
created in Mathematica (Wolfram). All gene expressions are expressed
as mean values of fold change ± standard deviations (SD). Hypothesis
testing was done by two-way ANOVAwith Dunnett's multiple compar-
ison test. Signiﬁcance is indicated as ***p b 0.001, **p b 0.01, *p b 0.05 in
the ﬁgures. Cell migration and invasion was analyzed by a linear mixed
model (Stata, StataCorp LP). An interaction term between treatment
and time allowed us to estimate the difference over time between the
transformed cell lines and the control cell line. To take into account
the dependency in the data, random effects were added for wells,
while a random slope for time accounted for different individual slopes
of the curve for each well. Finally, an autoregressive (AR) structure of
order 2 was assumed for the residuals.
3. Results
3.1. Transformation of HBEC2 and HBEC12
To gain insight into how tobacco related carcinogens transform
human bronchial epithelial cells we used two HBEC lines immortalized
with the CDK4 and hTERT genes (HBEC2-KT and HBEC12-KT) (Ramirez
et al., 2004). To test if exposure to CSCwas sufﬁcient to achieve transfor-
mation, HBEC lines were exposed for 12 weeks and then seeded in soft
agar. In parallel, both cell lines were exposed to the pre-carcinogenic
compound B[a]P or the direct acting carcinogen MNU. The toxicity of
MNU was different between the two cell lines, thus different doses
were used. HBEC12was themost readily transformed cell line, with col-
onies being observed after all treatments (Table 1). In contrast, HBEC2
was only transformed after exposure to CSC. Transformed cells were
subjected to a second round of soft agar colony formation to ensure sta-
ble transformation and true clonality. In total, 28 independent trans-
formed cell lines were established (four clones from each exposure;
termed A–D; Table 1). Neither HBEC2 nor HBEC12 treated with vehicle
for 12 weeks showed signs of colony formation in soft agar.
3.2. Transformed cells display characteristics of EMT
The mechanisms controlling the early stages of carcinogen induced
cell transformation are largely unknown. One suggested mechanism is
that cells undergo EMT to gain invasiveness and metastatic capacity.
While the vehicle treated cells in the present study retained an epithe-
lial morphology after 12 weeks of culturing, the transformed cells
displayed amorphology resembling that ofmesenchymal cells (Supple-
mentary Fig. S2). To investigate whether the transformed cell lines had
transitioned from an epithelial to a mesenchymal cell type, the expres-
sion levels of several genes known to be involved in EMTwere analyzed.]P
μM)
CSC
(1 μg/ml)
CSC
(3 μg/ml)
MNU
. + + (1 mM)
Neg.
T2KT-CSC-L T2KT-CSC-H
(A–D) (A–D)
+ + (0.5 mM)
+
KT-B[a]P-H T12KT-CSC-L T12KT-CSC-H T12KT-MNU
D) (A–D) (A–D) (A–D)
ticular exposure.
Fig. 1. Cadherin switch event in transformedHBECs. Cadherin expressionwasmeasured in untransformed and transformedHBEC2 andHBEC12 cell lines at the gene and protein level. (A)
and (C) Expression of CDH1 and CDH2mRNA in transformed HBEC2 and HBEC12 cells, respectively. Relative gene expression levels as compared to the particular untransformed control
cells are presented (fold change; 2−ΔΔCq). (B) and (D) Representative images from confocal immunoﬂuorescencemicroscopy of HBEC2 and HBEC12 control and transformed cells stained
for E-cadherin (B) and N-cadherin (D), respectively. Nuclear/DNA staining was done by Hoechst. Scale bar: 50 μm. T2KT: transformed HBEC2, T12KT: Transformed HBEC12, CSC-L:
cigarette smoke condensate 1.0 μg/μl, CSC-H: CSC 3.0 μg/μl, B[a]P-L: Benzo[a]pyrene 0.3 μM, B[a]P-H: B[a]P1.0 μM, MNU: Methylnitrosourea 0.5 mM. Gene expression data display
mean ± SD, n= 4, where each replicate represents clones isolated from individual colonies in soft-agar. ***p b 0.001 (ANOVA Dunnet's posttest).
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transformants of both HBEC2 and HBEC12, compared to untransformed
control cells (Fig. 1A). The transformed cell lines originating from
HBEC2 (CSC low and high dose) showed signiﬁcantly reduced expres-
sion of CDH1 (N2 × 103 times). Similarly, in HBEC12 transformed clones
exposed to either low or high dose of CSC, B[a]P, or single dose MNU,CDH1 was signiﬁcantly down-regulated between 10 and 104 times,
compared to the untransformed controls. In contrast, transformed
cells derived fromHBEC2 showed a signiﬁcant increase in CDH2 expres-
sion (N103 times) (Fig. 1C). In transformed cells derived from HBEC12,
only those arising from the high dose of CSC had signiﬁcantly increased
Fig. 2. Timing of the cadherin switch. Expression levels of CDH1 and CDH2were measured prior to selection for transformed cells in soft agar in HBEC2 cells exposed to low and high dose
CSC for 6, 9, and 12weeks. Relative gene expression levels as compared to the particular control cells (DMSO) are presented (fold change; mean± SD, n=4). **p b 0.01, and ***p b 0.001,
(ANOVA Dunnet's posttest).
Fig. 3. Expression of EMT marker genes in transformed HBEC lines. The expression of the EMT marker genes (A) SNAI1, (B) SNAI2, (C) TWIST, (D) ZEB1, (E) VIM, and (F) MMP2 was
measured in untransformed and transformed HBEC2 and HBEC12 cell lines. Relative gene expression levels as compared to the particular control cells (DMSO) are presented (fold
change; mean ± SD, n= 4). *p b 0.05, **p b 0.01, and ***p b 0.001, (ANOVA Dunnet's posttest).
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tively unaltered expression of CDH2.
Cadherin deregulation in HBEC2 transformants was also evident at
the protein level, when analyzed by ﬂuorescence microscopy (Fig. 1B).
In both untransformed HBEC2 and HBEC12, strong staining of E-
cadherinwas found in themembranes, especially of adherent cells indi-
cating its being organized in junctional adhesion. In contrast, E-cadherin
protein expression was abolished in transformed cell lines of both
HBEC2 and HBEC12, as exempliﬁed by B[a]P and CSC low dose, respec-
tively. N-cadherin showed little staining in untransformed cells but was
increased in transformed 2KT (T2KT-CSC-L and T2KT-CSC-H) compared
to the controls (Fig. 1D). For T12KTs, a slight increase in the ﬂuorescent
signal in the T12-KT-CSC-L cells was apparent, despite a non-signiﬁcant
change in mRNA levels.Fig. 4. In vitromigration and invasion capacity of HBEC2 cell lines. The capacity of untransform
measured by live cell imaging in a scratch wound healing assay (IncuCyte ZOOM). (A) Microsc
Black lines denote the original scratchwound and thewhite lines indicate themigration cell fron
different from that of 2KT-DMSO after 1 h until 30 h and further forward, and T2KT-CSC-H was
Microscope images of invading HBEC2, T2KT-CSC-L, and T2KT-CSC-H acquired at 0, 24, and 72
(B) Relative wound density. Migration of T2KT-CSC-L was signiﬁcantly different from that of 2K
(mixed models test, p b 0.05, n= 8).To ascertain the occurrence of the cadherin switch, expression of
CDH1 and CDH2 was measured in CSC exposed HBEC2 at different
time points prior to testing for soft agar colony formation. For short
term exposure to CSC (1 or 3 weeks) no changes in the expression of
CDH1 and CDH2 were apparent (data not shown). However, down-
regulation of CDH1 and up-regulation of CDH2 was observed after 6, 9,
and 12 weeks (Fig. 2). Thus, these data indicate that the timing of the
cadherin switch is in line with or precedes transformation of the
HBEC2 cell line.
Further evidence of EMT during in vitro cell transformation was
obtained from gene expression analyses of typical EMT markers
(Fig. 3). Expression of the EMT driver SNAI1 was signiﬁcantly up-
regulated in T2KT-CSC-L (15-fold; Fig. 3A). In T2KT-CSCH, a non-
signiﬁcant increase of SNAI1 mRNA was observed. In contrast,
SNAI2 was down-regulated in transformed HBEC2 as compared toed and transformed HBEC2 cell lines to migrate or invade through a matrigel in vitro was
ope images of migrating HBEC2, T2KT-CSC-L, and T2KT-CSC-H acquired at 0, 12, and 48 h.
t. Scale bar: 150 μm. (B) Relativewound density.Migration of T2KT-CSC-Lwas signiﬁcantly
signiﬁcantly different from 2KT-DMSO after 1 h (mixedmodels test, p b 0.05, n= 8). (C)
h. Black lines denote the original scratch wound and the white lines the invasive cell front.
T-DMSO after 4 h, and T2KT-CSC-Hwas signiﬁcantly different from 2KT-DMSO after 12 h
61A. Bersaas et al. / Toxicology in Vitro 35 (2016) 55–65the controls (approx. 25-fold; Fig. 3B). Furthermore, in the T2KT cell
lines increased gene expression levels were observed for other EMT
markers such as ZEB1 (N100-fold), VIM (N103-fold), and MMP2Fig. 5. FOXA1 and FOXA2 transcription factors are down-regulated in transformed cells. Expressio
and transformed HBEC2 and HBEC12 cell lines at the gene and protein level. (A) and (C) Expr
Relative gene expression levels as compared to the particular untransformed control c
immunoﬂuorescence microscopy of HBEC2 and HBEC12 control and transformed cells stained
Scale bar: 50 μm. T2KT: transformed HBEC2, T12KT: Transformed HBEC12, CSC-L: cigarette sm
B[a]P1.0 μM, MNU: Methylnitrosourea 0.5 mM. Gene expression data display mean ± SD,
***p b 0.001 (ANOVA Dunnet's posttest).(N103-fold). Expression of TWIST was also increased in T2KT cells,
but not signiﬁcantly.
Even though HBEC12 was the most readily transformed cell line,
it showed a less clear pattern of EMTmarkers. No signiﬁcant changesn of the pioneer transcription factors FOXA1 and FOXA2was investigated in untransformed
ession of FOXA1 and FOXA2mRNA in transformed HBEC2 and HBEC12 cells, respectively.
ells are presented (fold change). (B) and (D) Representative images from confocal
for FOXA1 (B) and FOXA2 (D), respectively. Nuclear/DNA staining was done by Hoechst.
oke condensate 1.0 μg/μl, CSC-H: CSC 3.0 μg/μl, B[a]P-L: Benzo[a]pyrene 0.3 μM, B[a]P-H:
n = 4, where each replicate are clones isolated from individual colonies in soft-agar.
62 A. Bersaas et al. / Toxicology in Vitro 35 (2016) 55–65were observed for SNAI1. However, SNAI2 was signiﬁcantly down-
regulated in all but one of the T12KT transformants (Fig. 3). The ex-
pression of ZEB1was signiﬁcantly increased in B[a]P and MNU trans-
formed T12KTs, but not in the CSC transformed cells. No signiﬁcant
changes were observed for any of the other EMT markers in T12KTs.
3.3. Cell migration and invasion
One characteristic of EMT is that it increases the cells migration and
invasion capabilities. A scratch-wound closure assay was performed to
test the capability of the untransformed and transformed HBEC2 cells
to migrate or to invade through a matrigel. All cell lines showed migra-
tion on the matrigel-coated surface (Fig. 4A). Interestingly, in case of
HBEC2, untransformed cells showed the fastest rate of migration and
complete closure was obtained after 12 h. T2KT-CSC-L and T2KT-CSC-
H closed the wound after approximately 20 and 35 h, respectively.
Statistically signiﬁcant differences from the untransformed cells were
observed between 1 and 30 h (T2KT-CSC-L) and from 1 h and beyond
(T2KT-CSC-H) (Fig. 4B). In the invasion assay, the transformed HBEC2
cells readily invaded through the matrigel (Fig. 4C). The T2KT-CSC-L
cell line closed the wound after approximately 30 h, whereas the
T2KT-CSC-H showed almost complete wound closure after 72 h. In con-
trast, although some wound intrusion was apparent in the untrans-
formed HBEC2 line during the ﬁrst 40 h of the assay, this leveled off
and further closure was not obtained. The invasiveness of T2KT-CSC-L
was signiﬁcantly different from that of untransformed HBEC2 after 4 h
and beyond, and for T2KT-CSC-H it was signiﬁcantly different from
12 h (mixed models, p b 0.05) (Fig. 4D). In addition to faster closure of
the scratch wound, the transformed cells also invaded by an apparent
different mechanism than the non-transformed cells including protru-
sions stretching into the matrigel (Supplementary Videos 1–3). Inter-
estingly, a few hours after addition of the matrigel the control cells
became less conﬂuent on either side of the wound. When embedded
in the matrigel the untransformed cells appeared to pack more tightly
together creating open areas within the monolayer (Fig. 4C).
3.4. FOXA1/2 pioneer TF's are down-regulated during cell transformation
Deregulation of the transcription factors FOXA1 and FOXA2has been
implicated in tumorigenesis and EMT. Here, the expression levels of the
FOXA1 and FOXA2 genes were down-regulated in all transformed cell
lines compared to controls (Fig. 5). In T2KTs, FOXA1 gene expression
was reduced by 2 × 105 and 3 × 105-fold for low and high concentration
of CSC exposure, respectively. In T12KTs, a smaller degree of down-reg-
ulation of FOXA1 was observed ranging between 10-fold and 100-fold
(Fig. 5A). The FOXA2 expression level in T2KT was reduced approx.
300-fold and 600-fold for low and high dose CSC, respectively, and for
T12KT the expression level was reduced between 40-fold and 103-fold
(Fig. 5C).
By ﬂuorescence microscopy analysis, untransformed control cells of
both HBEC2 and HBEC12 showed nuclear staining of FOXA1 (Fig. 5B).
FOXA1 expression was absent in T2KT-CSC-H and T12KT-CSC-L.Fig. 6.Down-regulation of FOXA1 and FOXA2 inHBEC2 after long-term exposure to CSC. Express
agar inHBEC2 cells exposed to low and highdose CSC for 6, 9, and 12weeks. Relative gene expre
mean ± SD, n= 4). **p b 0.01, and ***p b 0.001, (ANOVA Dunnet's posttest).Although FOXA1 mRNA was almost absent in T2KT-CSC-L there was
still some staining of FOXA1 in these cells. However, nuclear staining
was signiﬁcantly reduced compared to the untransformed HBEC2. In
transformed T12KT-B[a]P-L cells no clear evidence of reduced nuclear
staining was apparent. FOXA2 also showed nuclear staining in untrans-
formed HBEC2 and HBEC12 cells, whichwas signiﬁcantly reduced or al-
most abolished in the transformed cell lines (Fig. 5D). Thus, apart from
FOXA1 in T12KT-B[a]P-L, immunohistochemical analysis conﬁrmed the
gene expression measurements.
Interestingly, down-regulation of FOXA1 and FOXA2 mRNA was
observed in pre-transformed HBEC2 cells after 6, 9, and 12 weeks of
carcinogen exposure (Fig. 6), indicating that down-regulation of these
two transcription factors coincides or even precedes in vitro cell
transformation.
3.5. ChIP-qPCR
To investigate possible mechanisms of altered FOXA1 and FOXA2
gene expression, analysis of binding of selected histone variants was
performed. ChIP-qPCR assays for FOXA1 were designed within or close
to CpG-islands that are indicated to be bound by transcription factors
in the ENCODE database and have chromatin state (ChromHMM) of
promoter/enhancer (Fig. 7A). Binding of histone-H3 and the suppres-
sive histone variant macroH2A to FOXA1 was low at the transcription
start site in untransformed HBEC2, indicative of an open chromatin
state in the immediate vicinity of the transcription start site (TSS)
(Fig. 7B and C). A minor increase in binding of both histone variants
was observed at the TSS in both of the transformed cell lines. Histone-
H3 and macroH2A showed increased binding in transformed cell lines
at all the other sites analyzed, suggesting a more compact chromatin.
For the analysis of FOXA2, four genomic ChIP-qPCR assays were de-
signed in possible regulatory regions (ENCODE) (Fig. 7E). Histone H3
and macroH2A show increased binding in transformed cell lines in all
four assays with lower overall binding at the TSS (Fig. 7F and G).
Interestingly, binding of the histone variant H2A.Z, which has been
associatedwith destabilized and actively transcribed chromatin,was in-
creased in both FOXA1 and FOXA2 of transformed cells (Fig. 7D and H).
4. Discussion
HBEC2 and HBEC12 cells were exposed to CSC, B[a]P, or MNU for
12 weeks before selecting for transformed cells in a soft agar assay.
Prior to this study these cell lines have been immortalized by the inser-
tion of the CDK4 and TERT genes (Ramirez et al., 2004). They were char-
acterized as genomically stable, having few genetic changes and an
intact tumor protein p53 checkpoint, making them well suited for
lung carcinogenesis studies (Gazdar et al., 2010). While in the present
study, neither of the unexposed control cell lines showed signs of trans-
formation, tobacco carcinogen exposed cells formed colonies in soft
agar. It should be noted, however, that whereas CSC was able to induce
colony formation in both cell lines, B[a]P and MNU only produced colo-
nies in HBEC12 after exposure for 12 weeks.ion levels of FOXA1 and FOXA2weremeasured prior to selection of transformed cells in soft
ssion levels as compared to the particular control cells (DMSO) are presented (fold change;
Fig. 7.Alteredhistonebinding in genomic regions of FOXA1 and FOXA2. (A) and (E) ChIP-qPCRassays for FOXA1 and FOXA2were designed in, or close to,ﬁve and four genomic CpG-islands,
respectively. (B–D) FOXA1 and (F–H) FOXA2. Binding of histone variants is presented as percentage of input on pooled chromatin from four independent experiments.
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ized by loss of cell-to-cell contact and gain of increased invasion capabil-
ity. In this study, transformed cells showed characteristics of EMT,
including a signiﬁcant decrease of CDH1 gene expression and concor-
dantly reduced levels of E-cadherin protein. Loss of E-cadherin is associ-
ated with loss of epithelial phenotype and increased local invasiveness
and metastasis (Onder et al., 2008; Vleminckx et al., 1991). The loss of
E-cadherin and gain of N-cadherin (the “cadherin switch”) is considered
a hallmark of EMT. Although E-cadherin levels were reduced in both
T2KTs and T12KTs, only the T2KT cell lines showed signiﬁcantly in-
creased levels of N-cadherin. The reason for this discrepancy is not
known. The expression levels of CDH1 and CDH2 were signiﬁcantly
down- and up-regulated, respectively, prior to soft agar selection in
cells exposed to CSC for 6, 9, and 12weeks, compared to vehicle treated
cells. However, theHBECs did not become transformed before 12weeks
of exposure. These results indicate that although deregulation of the
cadherin switch may be important in enabling growth in soft agar, it is
not sufﬁcient.
Increased levels of SNAI1 and ZEB1mRNA expression was observed
in transformed HBEC2 cell lines, both of which are repressors of CDH1
gene expression (Batlle et al., 2000; Eger et al., 2005). In HBEC12
transformed cells, however, no signiﬁcant induction of SNAI1 was ob-
served. The level of ZEB1was increased in three out of ﬁve transformed
cell lines (T12KT-B[a]P-H, T12KT-B[a]P-L, and T12KT-MNU). Similar to
SNAI1 and ZEB1, SNAI2 is involved in repression of the CDH1 gene(Conacci-Sorrell et al., 2003). However, the expression patterns of the
repressors in the HBEC12 transformed cell lines were unclear and thus
it is plausible that additional mechanisms may be involved in the
regulation of CDH1. Indeed, it has been reported that reduced levels of
CDH1 can be attributed to increased DNAmethylation levels in the pro-
moter and translational suppression by binding of microRNA miR-9
(Lombaerts et al., 2006; Ma et al., 2010). Whether this is the case with
the transformed cell lines in this study remains to be clariﬁed.
Vimentin (VIM) andMMP2 are considered to play important roles in
regulating the cells invasiveness by modulating the cytoskeleton and
extracellular matrix, respectively (Giannelli et al., 1997; Ivaska et al.,
2007). In the transformed HBEC2 cell lines an increase in expression
of both these genes was observed, consistent with the invasive pheno-
type observed in the matrigel invasion assay. In HBEC12, the levels of
VIM andMMP2were unchanged similarly to the transcription levels of
the other EMT markers tested. These results suggest that although VIM
and MMP2may be important in the cells ability to grow in soft agar, a
change in the expression of these two genes is not the critical step for
gaining this ability.
A decrease in the gene expression level of SNAI2was observed in all
but one (T12KT-B[a]P-H) of the transformed cell lines. SNAI2 is, as
SNAI1 and ZEB1, known to suppress expression of CDH1. In addition,
SNAI2 expression has been shown to be suppressed by direct binding
of FOXA1 in its enhancer (Jin et al., 2013; Liu et al., 2012), thus it
would be expected that decreased FOXA1 expression levels would lead
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T2KT or T12KT cell lines suggesting that other mechanisms in addition
to FOXA1 may be important in regulating SNAI2 in human lung cells.
Consistent with the change in gene expression of the different EMT
markers, T2KT cells were able to invade a matrigel faster than control
cells. In addition, the morphology of invading cells was different in the
transformed vs control cells (Supplementary Fig. 2). In contrast, in-
creased migration rate was found in untransformed HBEC2 cells com-
pared to the transformed derivatives. The common interpretation is
that EMT and cell transformation involves increased invasiveness
often in conjunction with increased migration. Interestingly, in agree-
ment with our results it has been demonstrated that EMT can reduce
cellular migration while increasing in vitro invasiveness, indicating
that these processes may be uncoupled (Schaeffer et al., 2014).
In transformed cells originating from both HBEC2 and HBEC12 there
was a signiﬁcant reduction in the expression levels of FOXA1 and FOXA2.
The protein levels of both FOXA1 and FOXA2 in T2KT cells were also
reduced as observed by ﬂuorescent microscopy. For T12KTs, however,
differences in the ﬂuorescent signals were weak, but there was an indi-
cation of a difference in the protein levels. It is interesting to note that
the reduction of FOXA1/2 in exposed cells occurs prior to clonal selec-
tion in soft agar, indicating that FOXA1/2 deregulation may be an early
event.
FOXA1 has been shown to be important in transcriptional
reprogramming of EMT in several cancers, including lung cancer, and
N900 genes may be affected by FOXA1 deregulation (Jin et al., 2013;
Wang et al., 2013). Hence, if the FOXA1 transcriptional level is
deregulated by chemical exposure it may have great impact on the
chromatin landscape and on the transcriptional program of the cell
due to FOXA1s ability to bind compact chromatin and remodel chroma-
tin structure. In the prostate, FOXA1 has been found to positively
regulate CDH1, resulting in reduced invasiveness in vitro (Jin et al.,
2013). In a previous study on lung adenocarcinomas, FOXA1 was
overexpressed and ampliﬁed in a subset of the cases tested (Lin et al.,
2002). In another study, alterations in FOXA1 not only comprised gene
ampliﬁcation, but also deletion and sporadicmutation in lung adenocar-
cinoma (Li et al., 2013). Thus, it is apparent that regulation of FOXA1 in
lung cancer may be complex. However, down-regulation of FOXA1
during in vitro transformation with concomitant appearance of EMT is
in agreement with a role of FOXA1 in maintaining the epithelial pheno-
type. Interestingly, Jin et al. (2013) found that while FOXA1 is slightly
up-regulated in localized cancer of the prostate it is down-regulated in
metastatic prostate cancer. FOXA2may also suppress EMT and thereby
metastasis in human lung cancer cell lines (Tang et al., 2011). In agree-
ment with our study, FOXA2 was down-regulated in lung adenocarci-
nomas (Basseres et al., 2012).
The results of the present study indicate that the expression of the
FOXA genes is down-regulated by long-term carcinogen exposure, and
that this coincides with the occurrence of EMT. In our model, it is thus
reasonable to speculate that deregulation of FOXA1/FOXA2 and EMT
are associated, and that these mechanisms are involved in the tobacco
smoke carcinogen induced transformation of HBECs.
To get insight into the possible mechanisms involved in their down-
regulation, binding of histone H3 and the histone variant macroH2A in
the genomic regions surrounding FOXA1 and FOXA2 was quantitated
by ChIP-qPCR. These analyses included CpG islands, chromatin state,
and regions showing high TF binding in the FOXA1 and FOXA2 genes
that were all identiﬁed from the ENCODE database (UCSC Genome
Browser) (Fig. 7) (Kent et al., 2002; Rosenbloom et al., 2013). Lower his-
tone binding was found in regions surrounding the transcription start
site (TSS) in both FOXA1 and FOXA2, consistent with nucleosome deple-
tion around TSS (Lee et al., 2004). MacroH2A binds FOXA2 in cell lines
that do not express FOXA2 while being absent in cell lines that do ex-
press the gene (Barrero et al., 2013). This is consistent with our ﬁnding
of increased macroH2A binding in transformed cell lines. Interestingly,
for all investigated chromatin locations, higher levels of histone bindingwere found in the transformed cell lines (T2KT-CSC-L, T2KT-CSC-H)
compared to the control cell line. This result suggests a more compact
chromatin state surrounding the FOXA genes in the transformed cell
lines, consistent with the reduced level of transcription.
Using the same qPCR assays as above, the level of histone variant
H2A.Z was found to be increased in the transformed HBEC2 cell lines
when compared to the controls. H2A.Z preferentially binds in regions
ﬂanking TSS and is associated with nucleosome depletion and active
gene expression (Barski et al., 2007; Li et al., 2012). In gene bodies, how-
ever, increased H2A.Z has been associated with repression of gene ex-
pression (Zemach et al., 2010). This is in accordance with our results
for theGpG3 assays for both FOXA1 and FOXA2 (Fig. 7A and E). However,
the ﬁnding of increased H2A.Z in the other FOXA1 and FOXA2 genomic
regions tested was unexpected.
Exposure of HBECs to activated carcinogenic metabolites (such
as BPDE) has previously been shown to transform HBECs in vitro
(Damiani et al., 2008). In their paper, Damiani et al. (2008) showed
that E-cadherinwas down-regulated due to increased DNAmethylation
in theCDH1 promoter of transformed cells. Consistentwith their ﬁnding
we ﬁnd that all transformed cell lines have reduced levels of E-cadherin,
conﬁrming the importance of adherence proteins in the cell transforma-
tion process. Both HBEC2 andHBEC12were responsive to B[a]P and CSC
in regard to induction of typical PAH induced xenobiotic metabolism
genes like CYP1A1 and CYP1B1 (data not shown), indicating their ca-
pacity to metabolically activate PAH pro-carcinogens (Uppstad et al.,
2010). However, only in HBEC12 this resulted in transformed cells
after exposure to B[a]P.
Similarly to the ﬁndings reported by Damiani et al. (2008)), our
transformed cell lines were incapable of forming tumors in immunode-
ﬁcient nude mice (data not shown). This suggests that even though the
cells have gained some tumor cell characteristics including soft agar col-
ony formation, EMT and in vitro invasiveness, they have not developed
to become tumorigenic and the model may thus be representative of
early stages of lung carcinogenesis.
In summary, our results show that long-term exposure of immortal-
ized human bronchial epithelial cells to tobacco smoke carcinogens can
lead to cell transformation in vitro. The transformed cells are able to
grow anchorage independent and show increased invasiveness. In addi-
tion they have reduced expression of FOXA1 and FOXA2, co-occurring
with EMT. These results indicate that EMT and down-regulation of
FOXA1 and FOXA2 may be important in chemical carcinogen induced
transformation of human bronchial epithelial cells, and should stimu-
late further studies on their role in lung cancer.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.tiv.2016.04.012.
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